Journal of Nephropharmacology
SJR0.196
IR

Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.196 | Q3 | 27.1% | |
| 2024 | — | — | 0.205 | Q3 | 31.9% | |
| 2023 | — | — | 0.169 | Q4 | 29.0% | |
| 2022 | — | — | 0.218 | Q3 | 40.4% | |
| 2021 | — | — | 0.177 | Q4 | 35.3% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2345-4202
country
coverage
2019-2026